- Home
- CCCC vs WEYS Comparison
CCCC vs WEYS Comparison
Compare CCCC & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- WEYS
- Stock Information
- Founded
- CCCC 2015
- WEYS 1906
- Country
- CCCC United States
- WEYS United States
- Employees
- CCCC N/A
- WEYS N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- WEYS Apparel
- Sector
- CCCC Health Care
- WEYS Consumer Staples
- Exchange
- CCCC Nasdaq
- WEYS Nasdaq
- Market Cap
- CCCC 396.0M
- WEYS 337.8M
- IPO Year
- CCCC 2020
- WEYS N/A
- Fundamental
- Price
- CCCC $3.95
- WEYS $38.03
- Analyst Decision
- CCCC Buy
- WEYS
- Analyst Count
- CCCC 6
- WEYS 0
- Target Price
- CCCC $10.67
- WEYS N/A
- AVG Volume (30 Days)
- CCCC 1.9M
- WEYS 21.5K
- Earning Date
- CCCC 10-31-2024
- WEYS 11-05-2024
- Dividend Yield
- CCCC N/A
- WEYS 2.71%
- EPS Growth
- CCCC N/A
- WEYS N/A
- EPS
- CCCC N/A
- WEYS 3.02
- Revenue
- CCCC $33,668,000.00
- WEYS $290,409,000.00
- Revenue This Year
- CCCC $75.79
- WEYS N/A
- Revenue Next Year
- CCCC N/A
- WEYS N/A
- P/E Ratio
- CCCC N/A
- WEYS $12.60
- Revenue Growth
- CCCC 65.45
- WEYS N/A
- 52 Week Low
- CCCC $3.61
- WEYS $27.05
- 52 Week High
- CCCC $11.88
- WEYS $41.05
- Technical
- Relative Strength Index (RSI)
- CCCC 41.77
- WEYS 61.32
- Support Level
- CCCC $3.61
- WEYS $35.12
- Resistance Level
- CCCC $4.06
- WEYS $37.53
- Average True Range (ATR)
- CCCC 0.44
- WEYS 1.40
- MACD
- CCCC 0.01
- WEYS 0.27
- Stochastic Oscillator
- CCCC 22.82
- WEYS 97.03
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.